Search Results 881-890 of 3561 for Solid
The purpose of this study is to evaluate the safety, tolerability, and preliminary effectiveness of HMPL-306 in advanced or metastatic solid tumors with IDH ...
... solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which ...
... Solid Organ Transplantation. Jacksonville, Fla. The purpose of this study is to determine the safety of the SARS-CoV-2 vaccination in patients listed for solid ...
A Study of the Safety, Tolerability, Drug/Body Interactions, Biological and Clinical Activity of MSB0011359C (M7824) in Metastatic or Locally Advanced Solid ...
Outcomes Associated With Blastomycosis in Solid Organ and Hematopoietic Cell Transplant Recipients. Transpl Infect Dis. 2025 Mar-Apr; 27(2):e14430. Epub 2024 ...
The purpose of this study is to to characterize the safety, tolerability, and pharmacokinetics of MRTX1719 in patients with advanced solid tumor malignancies ...
... Solid Tumors (IGNYTE) A Study to Evaluate RP1 Monotherapy and Combined with Nivolumab NCT ID: NCT03767348 POC ID: CLS-20517717; Title: A Phase 1, Multicenter ...
... solid tumors, to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), as well as to evaluate preliminary effectiveness.
... solid-organ and hematopoietic stem cell transplant patients. You'll develop skills on an inpatient and outpatient setting in evaluating the febrile solid ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.